Novocure获得新的4亿美元多部分债务融资，股价上涨

2024-05-02 19:51

Novocure (NASDAQ:NVCR) Thursday said that it has entered into a new five-year up to $400 million committed senior secured credit facility with funds managed by Pharmakon Advisors, LP.
NVCR shares up +4.24% premarket to $13.28.
The committed capital will be available to Novocure in four tranches of $100 million. The first $100 million was issued at closing, and the second $100 million will be issued by June 30, 2025.
An additional $200 million is available to be drawn across two tranches, at Novocure’s discretion and subject to certain milestones, through March 31, 2026.
The proceeds will be used to fund working capital needs stemming from Novocure’s anticipated launch in non-small cell lung cancer and settle, upon maturity, Novocure’s convertible notes.
Source: Press Release

More on NovoCure